These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3735754)

  • 21. [Effect of apolipoprotein E gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease].
    Zhu T; Wang Z; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):149-51. PubMed ID: 10681829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E phenotype in demented patients in Greek population.
    Hatzifilippou E; Banaki T; Traka M; Koutsouraki E; Costa V; Baloyannis SJ
    Int J Neurosci; 2008 Jan; 118(1):163-72. PubMed ID: 18041613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the apolipoprotein E4 allele with hypercholesterolemia in apparently healthy male adults in Tokyo.
    Tsuchiya S; Yamanouchi Y; Miyazaki R; Yanagi H; Yamakawa K; Yuzawa K; Ohnuki M; Hamaguchi H
    Jinrui Idengaku Zasshi; 1987 Dec; 32(4):283-9. PubMed ID: 3454377
    [No Abstract]   [Full Text] [Related]  

  • 26. Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia.
    Pickar D; Malhotra AK; Rooney W; Breier A; Goldman D
    Lancet; 1997 Sep; 350(9082):930-1. PubMed ID: 9314875
    [No Abstract]   [Full Text] [Related]  

  • 27. Preliminary evidence for a role of apolipoprotein E alleles in identifying haemodialysis patients at high vascular risk.
    Olmer M; Renucci JE; Planells R; Bouchouareb D; Purgus R
    Nephrol Dial Transplant; 1997 Apr; 12(4):691-3. PubMed ID: 9140995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of apolipoprotein E allele substitutions on plasma lipid and apolipoprotein levels.
    Havekes LM; de Knijff P; Smit M; Frants RR
    Adv Exp Med Biol; 1988; 243():87-93. PubMed ID: 3066188
    [No Abstract]   [Full Text] [Related]  

  • 29. Apolipoprotein E4 is associated with primary localized cutaneous amyloidosis.
    Furumoto H; Hashimoto Y; Muto M; Shimizu T; Nakamura K
    J Invest Dermatol; 2002 Aug; 119(2):532-3. PubMed ID: 12190881
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasma apolipoprotein E levels in hyperlipidemia (author's transl)].
    Yamada N; Murase T; Akanuma Y; Kosaka K
    Nihon Naika Gakkai Zasshi; 1981 Sep; 70(9):1249-53. PubMed ID: 7320607
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of serum apolipoprotein E4 isoprotein is not increased in rheumatoid arthritis patients with amyloidosis: comment on the article by Hasegawa et al.
    Korpela M; Lehtimäki T; Mustonen J; Pasternack A
    Arthritis Rheum; 1998 Jul; 41(7):1328-9. PubMed ID: 9663498
    [No Abstract]   [Full Text] [Related]  

  • 32. Apolipoprotein E4 in Parkinson's disease.
    Korczyn AD
    Neurology; 1995 May; 45(5):1025. PubMed ID: 7746382
    [No Abstract]   [Full Text] [Related]  

  • 33. The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent.
    Smith JD; Miyata M; Poulin SE; Neveux LM; Craig WY
    Int J Clin Lab Res; 1998; 28(2):116-21. PubMed ID: 9689554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged men.
    Mänttäri M; Manninen V; Palosuo T; Ehnholm C
    Atherosclerosis; 2001 May; 156(1):237-8. PubMed ID: 11417521
    [No Abstract]   [Full Text] [Related]  

  • 35. Apolipoprotein E Arg136 --> Cys mutation and hyperlipidemia in a large central European population sample.
    Hubacek JA; Adamková V; Stavek P; Kubinova R; Peasey A; Pikhart H; Marmot M; Bobak M
    Clin Chim Acta; 2008 Feb; 388(1-2):217-8. PubMed ID: 18326082
    [No Abstract]   [Full Text] [Related]  

  • 36. Variability of lipid phenotypes in hyperuricaemic-hyperlipidemic patients.
    Collantes E; Tinahones FJ; Cisnal A; Añon J; Sanchez-Guijo P
    Clin Rheumatol; 1994 Jun; 13(2):244-7. PubMed ID: 8088067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E and epilepsy.
    Kilpatrick ES; Jagger CE; Spooner RJ; Brodie MJ
    Ann Clin Biochem; 1996 Mar; 33 ( Pt 2)():146-7. PubMed ID: 8729723
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid metabolism.
    Giddings JC
    Curr Opin Lipidol; 1997 Aug; 8(4):U51-3. PubMed ID: 9253545
    [No Abstract]   [Full Text] [Related]  

  • 39. What is the role of apolipoprotein E for cognitive functioning across the lifespan?
    Sternäng O; Wahlin A
    Biol Psychiatry; 2011 Jul; 70(2):109-10. PubMed ID: 21708302
    [No Abstract]   [Full Text] [Related]  

  • 40. Apolipoprotein E phenotype and blood pressure.
    de Knijff P; Boomsma DI; Feskens EJ; Jespersen J; Johansen LG; Kluft C; Kromhout D; Havekes LM
    Lancet; 1994 May; 343(8907):1234-5. PubMed ID: 7909906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.